Confidence in the scientific community declined among U.S. adults in 2022, a major survey shows, driven by a partisan divide in views of both science and medicine that emerged during the COVID-19 pandemic.

Overall, 39% of U.S. adults said they had “a great deal of confidence” in the scientific community, down from 48% in 2018 and 2021. That's according to the General Social Survey, a long-running poll conducted by NORC at the University of Chicago that has monitored Americans’ opinions on key topics since 1972.

An additional 48% of adults in the latest survey reported “only some” confidence, while 13% reported “hardly any,” according to an analysis of the survey by The Associated Press-NORC Center for Public Affairs Research.

The survey showed low confidence levels among Republicans as partisan gaps that emerged during the pandemic era have stuck around, said Jennifer Benz, the center's deputy director.

“It doesn’t look all that dramatic when you just look at the trends for the overall public,” Benz said. “But when you dig into that by people’s political affiliations, there’s a really stark downturn and polarization.”

Between surveys in 2018 and 2021, as the pandemic took hold, the major parties’ trust levels headed in opposite directions. Democrats reported a growing level of confidence in science in 2021 — perhaps as a “rallying effect” around things like COVID-19 vaccines and prevention measures, Benz said. At the same time, Republicans saw their confidence start to plummet.

In the 2022 survey, Democrats’ confidence fell back to around pre-pandemic levels, with 53% reporting a great deal of confidence compared with 55% in 2018. But Republicans’ confidence continued its downward trend, dropping to 22% from 45% in 2018. Confidence in medicine has also grown more polarized since 2018. That year, Democrats and Republicans were about equally likely to say they had high confidence. By 2022, though, Republicans’ confidence had fallen to 26%, while Democrats’ has remained about the same as it was before the pandemic, at 42%.

Overall, 34% of Americans reported a great deal of confidence in medicine in 2022, compared with 39% before the pandemic.

Generally, scientists have had a high level of trust compared to other groups in the U.S., said John Besley, who studies public opinion about science at Michigan State University. And even with the latest declines, confidence in science is still higher than many other institutions, he pointed out.

But the split between political parties is a cause for concern, experts said.

“You can definitely see the impact here of people taking cues from their political leaders,” Benz said.

For Sudip Parikh, CEO of the American Association for the Advancement of Science, the drops were “disappointing but not surprising.” He sees them as part of an “overall pulling apart of our communities” and a loss of trust in many institutions.

The latest survey found that distrust has grown for some other groups, too. According to the 2022 survey, confidence in the Supreme Court has plunged to its lowest level in at least 50 years. Americans also reported lower levels of trust in education, the press, major companies and organized religion.

Besley said that scientists should communicate about their motives to help show that they are trustworthy: “Not only do we have some expertise, but that also we’re using that expertise to try to make the world better,” he said.

Parikh thought the stakes are high for rebuilding trust in science — and doing so across political lines.

“Science must be bipartisan,” he said. “The causes of Alzheimer’s are the same whether you’re a Republican or a Democrat. The fusion that goes on in the sun is the same whether you live in Topeka or you live in San Francisco.”

The General Social Survey has been conducted since 1972 by NORC at the University of Chicago. Sample sizes for each year’s survey vary from about 1,500 to about 4,000 adults, with margins of error falling between plus or minus 2 percentage points and plus or minus 3.1 percentage points. The most recent survey was conducted May 5, 2022, through Dec. 20, 2022, and includes interviews with 3,544 American adults. Results for the full sample have a margin of error of plus or minus 3 percentage points.

Share:
More In Science
Beyond Meat Expands McDonald's Deal As Fast Food Reign Continues
Plant-based meat giant Beyond Meat's reign over the fast food world continues, as McDonald's announced that it is expanding its test of Beyond's McPlant burger, to nearly 600 restaurants, an increase from the eight that it's been testing in since November. This comes less than two weeks after Beyond Fried Chicken made its nationwide debut at KFC restaurants, the first time that plant based chicken has been widely distributed in a fast food capacity. Arun Sundaram, Senior Equity Analyst at CFRA Research explains why these latest collaborations may be proof that Beyond Meat products could slowly be becoming an unlikely staple in the fast food and chain restaurant world as consumers opt for more healthy food options.
BD Veritor Hopes to Take 'Guesswork' Out With Smartphone-Enabled COVID Test
BD Veritor is a variation of the at-home COVID test that uses a smartphone to interpret the results. The test is taken via a nose swab test strip that is then scanned by your phone’s camera with the result clearly displayed as positive or negative. James Walker, vice president of integrated diagnostics USA for BD, joined Cheddar to discuss how the test hopefully takes the "guesswork out of testing." Walker also went into what BD is doing to deal with the surging demand for at-home tests amid the omicron spread. "While we don't disclose how much we produce, we have capacity to manufacture up to 12 million rapid antigen tests per month and are delivering on our commitments to distributors and retailers," he said.
Robotics for Eyelash Extensions; Innovation in Food Tech
On this episode of Cheddar Innovates: Sidechef CEO breaks down how it's building a platform to make recipe shopping easy; Luum CEO explains the process of having a robot put on eyelash extensions; A look at Curiosity Stream's new original series, 'Evolve.'
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Beijing Pledges to Host 'Low Carbon' Olympic Games
With the 2022 Beijing Winter Olympics right around the corner, experts are warning that climate change is threatening not only the event but also the future of snow sports. Despite being the world's top polluter, China is hoping to use the event to demonstrate the country's commitment to fighting climate change, and pledging to host a "low carbon" games. Xubin Zeng, professor of hydrology and atmospheric sciences at the University of Arizona, joins Cheddar News.
Study Finds Payments for Low-Income Mothers May Impact Infants' Brains
New research is suggesting that giving extra cash to low-income mothers can actually influence the brain development of their infants. These findings provide the first rigorous evidence of how payments and monetary support can affect children in the early years of life. Authors of the study, Nathan Fox, professor in the department of human development at the University of Maryland, and Sonya Troller-Renfree, postdoctoral research associate at Teachers College at Columbia University, join Cheddar News to discuss.
Load More